Simplex Trading, LLC Cel Sci Corp Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

A detailed history of Simplex Trading, LLC transactions in Cel Sci Corp stock. As of the latest transaction made, Simplex Trading, LLC holds 1,002 shares of CVM stock, worth $621. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,002

Previous 13,714 92.69%

Holding current value

$621

Previous $15,000 93.33%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$1.05 - $1.5 $13,347 - $19,068	-12,712 Reduced 92.69%	1,002 $1,000
Q2 2024 Jul 25, 2024	SELL	$1.11 - $1.85 $19,591 - $32,652	-17,650 Reduced 56.27%	13,714 $15,000
Q1 2024 Apr 25, 2024	BUY	$1.63 - $3.08 $4,682 - $8,848	2,873 Added 10.08%	31,364 $59,000
Q4 2023 Feb 02, 2024	BUY	$1.07 - $3.07 $9,506 - $27,276	8,885 Added 45.32%	28,491 $77,000
Q3 2023 Nov 01, 2023	BUY	$1.17 - $2.86 $12,072 - $29,509	10,318 Added 111.09%	19,606 $24,000
Q2 2023 Aug 04, 2023	BUY	$2.11 - $2.83 $18,732 - $25,124	8,878 Added 2165.37%	9,288 $22,000
Q1 2023 Apr 27, 2023	SELL	$2.17 - $3.13 $29,646 - $42,762	-13,662 Reduced 97.09%	410 $0
Q4 2022 Feb 02, 2023	SELL	$1.99 - $3.52 $31,849 - $56,337	-16,005 Reduced 53.21%	14,072 $33,000
Q3 2022 Nov 04, 2022	BUY	$3.09 - $5.23 $43,182 - $73,089	13,975 Added 86.79%	30,077 $92,000
Q2 2022 Aug 03, 2022	BUY	$2.58 - $4.99 $41,336 - $79,949	16,022 Added 20027.5%	16,102 $72,000
Q1 2022 May 02, 2022	SELL	$3.93 - $7.7 $205,802 - $403,225	-52,367 Reduced 99.85%	80 $0
Q3 2021 Oct 28, 2021	SELL	$7.64 - $12.49 $118,504 - $193,732	-15,511 Reduced 22.82%	52,447 $453,000
Q2 2021 Aug 12, 2021	BUY	$8.68 - $27.49 $589,875 - $1.87 Million	67,958 New	67,958 $589,000
Q4 2020 Feb 02, 2021	SELL	$11.05 - $16.62 $37,304 - $56,109	-3,376 Closed	0 $0
Q3 2020 Oct 14, 2020	SELL	$11.69 - $14.54 $127,783 - $158,936	-10,931 Reduced 76.4%	3,376 $0
Q2 2020 Jul 13, 2020	SELL	$9.75 - $17.6 $507,750 - $916,555	-52,077 Reduced 78.45%	14,307 $213,000
Q1 2020 Apr 29, 2020	BUY	$7.54 - $17.05 $500,535 - $1.13 Million	66,384 New	66,384 $766,000
Q4 2019 Feb 05, 2020	SELL	$6.71 - $9.55 $121,108 - $172,367	-18,049 Closed	0 $0
Q3 2019 Oct 15, 2019	BUY	$6.0 - $9.6 $54,498 - $87,196	9,083 Added 101.3%	18,049 $161,000
Q2 2019 Jul 26, 2019	BUY	$3.77 - $8.67 $33,801 - $77,735	8,966 New	8,966 $75,000

Others Institutions Holding CVM

# of Institutions

Shares Held

Call Options Held

27.1K

Put Options Held

150K

View Full List

About CEL SCI CORP

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $26.9M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

More about CVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Cel Sci Corp Transaction History